Copayment Adjustments Under Bundled and Two-Tiered Pricing: Welfare Implications for Outpatient Care in Taiwanese Hospitals
Related Experiment Video
Updated: Sep 9, 2025

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
1National Taichung University of Science and Technology, Taiwan.
Abstract:
This study investigates the welfare implications of copayment adjustments on non-prescription drug services and prescription drugs provided through outpatient care in Taiwan's hospitals under the bundled and 2-tiered pricing scheme. The novelty of this study lies in its analysis of the welfare effects of outpatient copayments under this pricing structure. Structural change models were employed to estimate the welfare effects of copayment adjustments. The analysis reveals that higher copayments prior to physician consultations may lead to a pricing-out effect for low-income individuals in medical centers, while the impact is negligible in regional hospitals. The estimated willingness-to-pay (WTP) for an outpatient visit involving regular and refillable prescription drugs in medical centers is approximately NT$2024 (95% CI: [1978, 2072]) and NT$2312 (95% CI: [2267, 2357]), respectively. These values are 1.71 to 1.87 times higher than the WTP for comparable outpatient visits in regional hospitals, with estimates for regular (NT$1078; 95% CI: [1045, 1111]) and refillable prescription drugs (NT$1353; 95% CI: [1304, 1400]). The WTP for prescription drugs bundled within an outpatient visit ranges from NT$939 (95% CI: [908, 971]) to NT$1210 (95% CI: [1174, 1244]) in medical centers and from NT$308 (95% CI: [293, 322]) to NT$544 (95% CI: [514, 574]) in regional hospitals. Additionally, the share of deadweight loss (DWL) per outpatient visit attributable to regular prescription drugs (with a cost-sharing scheme) ranges from 14.58% to 31.15%, which is significantly lower than that attributable to refillable prescription drugs (without a cost-sharing scheme), ranging from 17.32% to 42.80%. Our findings highlight the underestimation of welfare effects from copayment policy changes and emphasize the 2-tiered scheme as an effective approach to mitigating DWL in outpatient care utilization in Taiwan's hospitals.
More Related Videos
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Secondary Healthcare System
Hospitals-I
Tertiary Healthcare System
Hospitals-II
Nurses that work in...